| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A novel “in-feed” delivery platform applied for oral DNA vaccination against IPNV enables high protection in Atlantic salmon (Salmon salar)
|
Reyes, Miguel
|
|
2017
|
35 |
4 |
p. 626-632
|
artikel
|
| 2 |
B cell and antibody responses in mice induced by a putative cell surface peptidase of Pneumocystis murina protect against experimental infection
|
Ruan, Sanbao
|
|
2017
|
35 |
4 |
p. 672-679
|
artikel
|
| 3 |
Comparison of functional assays used in the clinical development of a placental malaria vaccine
|
Pehrson, Caroline
|
|
2017
|
35 |
4 |
p. 610-618
|
artikel
|
| 4 |
Corrigendum to “Trends in childhood vaccine purchase costs in the US public sector: 1996–2014” [Vaccine 34 (2016) 4706–4711]
|
Chen, Weiwei
|
|
2017
|
35 |
4 |
p. 711
|
artikel
|
| 5 |
Cost-effectiveness of increasing cervical cancer screening coverage in the Middle East: An example from Lebanon
|
Sharma, Monisha
|
|
2017
|
35 |
4 |
p. 564-569
|
artikel
|
| 6 |
Defining cases of severe pediatric diarrhea for an efficacy trial of an enterotoxigenic Escherichia coli (ETEC) vaccine: Report on an international workshop, Washington DC, March 2016
|
Wierzba, Thomas F.
|
|
2017
|
35 |
4 |
p. 503-507
|
artikel
|
| 7 |
Development of bioluminescence imaging of respiratory syncytial virus (RSV) in virus-infected live mice and its use for evaluation of therapeutics and vaccines
|
Fuentes, Sandra
|
|
2017
|
35 |
4 |
p. 694-702
|
artikel
|
| 8 |
Editorial Board/Aims and Scope
|
|
|
2017
|
35 |
4 |
p. IFC
|
artikel
|
| 9 |
Effectiveness of MF59-adjuvanted seasonal influenza vaccine in the elderly: A systematic review and meta-analysis
|
Domnich, Alexander
|
|
2017
|
35 |
4 |
p. 513-520
|
artikel
|
| 10 |
Extensive swelling of the limb and systemic symptoms after a fourth dose of acellular pertussis containing vaccines in England in children aged 3–6years
|
Southern, Jo
|
|
2017
|
35 |
4 |
p. 619-625
|
artikel
|
| 11 |
First-in-human safety and immunogenicity investigations of three adjuvanted reduced dose inactivated poliovirus vaccines (IPV-Al SSI) compared to full dose IPV Vaccine SSI when given as a booster vaccination to adolescents with a history of IPV vaccination at 3, 5, 12months and 5years of age
|
Lindgren, Line M.
|
|
2017
|
35 |
4 |
p. 596-604
|
artikel
|
| 12 |
Hospitalizations within 14days of vaccination among pediatric recipients of the live attenuated influenza vaccine, United States 2010–2012
|
Millman, Alexander J.
|
|
2017
|
35 |
4 |
p. 529-535
|
artikel
|
| 13 |
Identification of amino acids in antigen-binding site of class II HLA proteins independently associated with hepatitis B vaccine response
|
Sakai, Aiko
|
|
2017
|
35 |
4 |
p. 703-710
|
artikel
|
| 14 |
Immune protection conferred by recombinant MRLC (myosin regulatory light chain) antigen in TiterMax Gold® adjuvant against experimental fasciolosis in rats
|
Henker, Luan C.
|
|
2017
|
35 |
4 |
p. 663-671
|
artikel
|
| 15 |
Impact of the national rotavirus vaccination programme on acute gastroenteritis in England and associated costs averted
|
Thomas, Sara L.
|
|
2017
|
35 |
4 |
p. 680-686
|
artikel
|
| 16 |
Interest in an Ebola vaccine among a U.S. national sample during the height of the 2014–2016 Ebola outbreak in West Africa
|
Painter, Julia E.
|
|
2017
|
35 |
4 |
p. 508-512
|
artikel
|
| 17 |
Knowledge and recommendation regarding routine childhood vaccinations among pediatric healthcare providers in Israel
|
Shibli, Rana
|
|
2017
|
35 |
4 |
p. 633-638
|
artikel
|
| 18 |
Negative impact of prior influenza vaccination on current influenza vaccination among people infected and not infected in prior season: A test-negative case-control study in Japan
|
Saito, Nobuo
|
|
2017
|
35 |
4 |
p. 687-693
|
artikel
|
| 19 |
Outer membrane vesicles harboring modified lipid A moiety augment the efficacy of an influenza vaccine exhibiting reduced endotoxicity in a mouse model
|
Lee, Tae-Young
|
|
2017
|
35 |
4 |
p. 586-595
|
artikel
|
| 20 |
Passive antibodies derived from intramuscularly immunized toxoid fusion 3xSTaN12S-dmLT protect against STa+ enterotoxigenic Escherichia coli (ETEC) diarrhea in a pig model
|
Nandre, Rahul M.
|
|
2017
|
35 |
4 |
p. 552-556
|
artikel
|
| 21 |
Pregnancy as a risk factor for severe outcomes from influenza virus infection: A systematic review and meta-analysis of observational studies
|
Mertz, Dominik
|
|
2017
|
35 |
4 |
p. 521-528
|
artikel
|
| 22 |
Primary care physicians’ perspective on financial issues and adult immunization in the Era of the Affordable Care Act
|
Hurley, Laura P.
|
|
2017
|
35 |
4 |
p. 647-654
|
artikel
|
| 23 |
Real-time dynamic modelling for the design of a cluster-randomized phase 3 Ebola vaccine trial in Sierra Leone
|
Camacho, A.
|
|
2017
|
35 |
4 |
p. 544-551
|
artikel
|
| 24 |
Risk factors related to the failure of prevention of hepatitis B virus Mother-to-Child transmission in Yunnan, China
|
Kang, Wenyu
|
|
2017
|
35 |
4 |
p. 605-609
|
artikel
|
| 25 |
Sequential administration of a MVA-based MUC1 cancer vaccine and the TLR9 ligand Litenimod (Li28) improves local immune defense against tumors
|
Schaedler, Emmanuelle
|
|
2017
|
35 |
4 |
p. 577-585
|
artikel
|
| 26 |
The economic impact of prenatal varicella immunity among pregnant women in Alberta
|
Passi, Amrit
|
|
2017
|
35 |
4 |
p. 570-576
|
artikel
|
| 27 |
Unique cellular and humoral immunogenicity profiles generated by aerosol, intranasal, or parenteral vaccination in rhesus macaques
|
Bolton, Diane L.
|
|
2017
|
35 |
4 |
p. 639-646
|
artikel
|
| 28 |
Vaccination of alpacas against Rift Valley fever virus: Safety, immunogenicity and pathogenicity of MP-12 vaccine
|
Rissmann, M.
|
|
2017
|
35 |
4 |
p. 655-662
|
artikel
|
| 29 |
Vaccination of rhesus macaques with the live-attenuated HSV-1 vaccine VC2 stimulates the proliferation of mucosal T cells and germinal center responses resulting in sustained production of highly neutralizing antibodies
|
Stanfield, Brent A.
|
|
2017
|
35 |
4 |
p. 536-543
|
artikel
|
| 30 |
Viral vector vaccines protect cockatiels from inflammatory lesions after heterologous parrot bornavirus 2 challenge infection
|
Runge, Solveig
|
|
2017
|
35 |
4 |
p. 557-563
|
artikel
|
Tijdschrift beschrijving